LON:GENI GENinCode (GENI) Share Price, News & Analysis → only trade options on these 5-7 stocks (From Prosper Trading Academy) (Ad) Free GENI Stock Alerts GBX 6.76 -0.09 (-1.31%) (As of 06:42 AM ET) Add Compare Share Share Today's Range 6.75▼ 7.5050-Day Range 6.25▼ 9.4452-Week Range 3.34▼ 14Volume190,922 shsAverage Volume284,761 shsMarket Capitalization£11.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get GENinCode alerts: Email Address Ad Prosper Trading Academyonly trade options on these 5-7 stocksI'm going to reveal the only 5-7 stocks you should be trading. But here's the secret - there's nothing special about these stocks. What matters is the repeatable options trading system I use to trade them.Click here to download my options trading cheat sheet (5-7 stocks inside here) About GENinCode Stock (LON:GENI)GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis; and Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.Read More GENI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GENI Stock News HeadlinesJune 14 at 5:06 AM | americanbankingnews.comGENinCode (LON:GENI) Trading Up 16.7%October 30, 2023 | finance.yahoo.comCARDIO inCode Study Results Presented at ESC Annual MeetingAugust 16, 2023 | marketwatch.comGENinCode Shares Rise on FDA Filing for Heart Disease Test KitJuly 19, 2023 | lse.co.ukGENinCode and MedStar collaborate on coronary heart disease testingJuly 19, 2023 | marketwatch.comGENinCode Collaborates With MedStar Health for Coronary Heart Disease TestJuly 14, 2023 | msn.comGenetic testing could bring in ‘new age’ of diagnostics in NHSJune 6, 2023 | lse.co.ukGENinCode annual loss widens; focuses on US, EU, and NHS in UKMay 21, 2023 | finance.yahoo.comShould You Investigate Genius Sports Limited (NYSE:GENI) At US$5.18?May 2, 2023 | lse.co.ukUK National Health Service to hike use of GENinCode heart disease testMay 2, 2023 | marketwatch.comGENinCode's Heart Disease Test Gets Accelerated Use in UK; Shares RiseJanuary 3, 2023 | lse.co.ukGENinCode shares surge amid state licence approval for California labOctober 21, 2022 | finance.yahoo.comGenius Sports (NYSE:GENI) shareholders have endured a 78% loss from investing in the stock a year agoSeptember 29, 2022 | lse.co.ukEARNINGS UPDATES: Transence Tech swings to profit; Curzon widens lossAugust 5, 2022 | ca.finance.yahoo.comGENinCode plc (GENI.L)July 8, 2022 | uk.investing.comShenzhen Techwinsemi Technology Co Ltd (001309)July 8, 2022 | uk.investing.comNordic Lights Group Oy (NORDLIG)July 3, 2022 | lse.co.ukDas (RBI): "Cryptocurrencies are a clear danger, their value is based on fantasy"July 3, 2022 | lse.co.ukUPDATE: Braemar Shipping delays publication of results; outlook goodSee More Headlines Receive GENI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:GENI CUSIPN/A CIKN/A Webwww.genincode.com Phone44 1865 955 847FaxN/AEmployees34Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-6,730,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-84.23% Return on Assets-43.64% Debt Debt-to-Equity Ratio6.74 Current Ratio5.92 Quick Ratio15.89 Sales & Book Value Annual Sales£1.72 million Price / Sales6.96 Cash FlowGBX 8.12 per share Price / Cash Flow0.83 Book ValueGBX 5 per share Price / Book1.35Miscellaneous Outstanding Shares176,960,000Free FloatN/AMarket Cap£11.97 million OptionableNot Optionable Beta0.62 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Matthew Heaton Walls (Age 60)Co-Founder, CEO & Director Comp: $336.54kMr. Jordi Puig Gilberte (Age 49)Co-Founder, COO & Director Comp: $149.16kMr. Paul Andrew Peter Foulger (Age 55)CFO, Company Secretary & Director Comp: $150.07kKey CompetitorsANGLELON:AGLVerici DxLON:VRCIYourgene HealthLON:YGENAbingdon HealthLON:ABDXProteome SciencesLON:PRMView All Competitors GENI Stock Analysis - Frequently Asked Questions How have GENI shares performed in 2024? GENinCode's stock was trading at GBX 5.25 on January 1st, 2024. Since then, GENI shares have increased by 28.9% and is now trading at GBX 6.77. View the best growth stocks for 2024 here. How do I buy shares of GENinCode? Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:GENI) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredThis AI made her leave her jobThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.